stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Stem Cells Hold Keys for Idiopathic Pulmonary Fibrosis

Posted by pamela@stemsave.com on Nov 4, 2016 5:46:05 PM

o-CLINICAL-TRIAL-facebook.jpgResearchers from the University of Pittsburg School of Medicine are utilizing mesenchymal stem cells [MSCs] to develop a treatment for Idiopathic Pulmonary Fibrosis (IPF). MSCs possess valuable properties that make them particularly suitable for potential treatments – chief amongst them are; their plasticity [ability to differentiate into a particular tissue type], their anti-inflammatory capabilities and, their immunomodulatory properties. Currently, there are five Phase 1 clinical trials registered utilizing MSCs to treat IPF.

MSCs are the type of stem cell found in dental pulp. By banking their own valuable stem cells, families can ensure that they will have access to emerging regenerative therapies. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.

 

The Future of Regenerative Medicine is Now™

To view the full article, click here.

Topics: idiopathic pulmonary fibrosis, regenerative therapies, dental pulp, mesenchymal stem cells, autologous stem cells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all